Lupus Therapeutics Statement on Positive Data from Phase 3 PHOENYCS GO Trial in Moderate-To-Severe Systemic Lupus
WASHINGTON, D.C., November 19, 2024 — Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance (LRA), is encouraged...